Cargando…
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice
Direct oral anticoagulants (DOACs) are a more manageable alternative than vitamin K antagonists (VKAs) to prevent stroke in patients with nonvalvular atrial fibrillation and to prevent and treat venous thromboembolism. Despite their widespread use in clinical practice, there are still some unresolve...
Autores principales: | Roberti, Roberta, Iannone, Luigi Francesco, Palleria, Caterina, Curcio, Antonio, Rossi, Marco, Sciacqua, Angela, Armentaro, Giuseppe, Vero, Ada, Manti, Antonia, Cassano, Velia, Russo, Emilio, De Sarro, Giovambattista, Citraro, Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188985/ https://www.ncbi.nlm.nih.gov/pubmed/34122113 http://dx.doi.org/10.3389/fphar.2021.684638 |
Ejemplares similares
-
Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes
por: Cassano, Velia, et al.
Publicado: (2022) -
Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs
por: Galgani, Alessandro, et al.
Publicado: (2018) -
Corrigendum: Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs
por: Galgani, Alessandro, et al.
Publicado: (2020) -
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study
por: Barbieri, Maria Antonietta, et al.
Publicado: (2020) -
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study
por: Iannone, Luigi Francesco, et al.
Publicado: (2020)